Nosele SRL
1.4 FTEThe score of Nosele shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +132 % Total assets +61 % Headcount (avg FTE) +8 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Nosele's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 89,095 € | ||||
| Equity | 263,979 € | ||||
| Cash | 26,977 € | ||||
| EBITDA | 145,528 € | ||||
| Total assets | 364,582 € |
Filed annual accounts
- Year ended 01 Apr 2025filed on 25 Nov 2025
- Year ended 01 Apr 2024filed on 20 Nov 2024
- Year ended 01 Apr 2023filed on 30 Nov 2023
- Year ended 01 Apr 2022filed on 01 Dec 2022
- Year ended 01 Apr 2021filed on 01 Dec 2021
Nosele's financial analysis
- Solvency72.4%sector median: 67.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Nosele
Nosele's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0876.435.778
- VAT number
- BE0876435778
- Peppol
- Registered · 0208:0876435778 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Oct 2005
- Registered office
- 1150 Woluwe-Saint-Pierre
- Size
- Micro · 1.4 FTE
- Latest accounts
- 2025 · filed on 25 Nov 2025
- Activity
- Medical specialists activities (NACE 86220)
Nosele (SRL) has been based in Woluwe-Saint-Pierre since 2005, active in: medical specialists activities. For 2025, it reports a net profit of 89,095 € and equity of 263,979 €; its revenue is not published. With 1.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 72.4%, above the median of its sector (67.6%).
Companies similar to Nosele
Companies in the same business, of comparable size and area, outside its group.
- Docteur Jean-Michel KNOTT Medical specialists activities Theux · balance sheet 364,600 €
- Dr. C. Kesteloot Medical specialists activities Grimbergen · balance sheet 364,478 €
- Dermatologie Delvoye Pierre Medical specialists activities Liège · balance sheet 364,470 €
- DR. Evelyne Declercq - Inwendige Geneeskunde - Endocrinologie Medical specialists activities Lievegem · balance sheet 364,397 €
- Dokter JAN Vandereycken Medical specialists activities Sint-Martens-Latem · balance sheet 364,844 €
- iCOAST Medical specialists activities Thimister-Clermont · balance sheet 364,895 €
- Medihubr Medical specialists activities Liège · balance sheet 364,211 €
- Ambax Medical specialists activities Merelbeke-Melle · balance sheet 365,244 €
Frequently asked questions about Nosele
What is the revenue of Nosele?
Nosele files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Nosele?
In Belgium, the VAT number is the company number prefixed with BE: BE0876435778 for Nosele, if the company is VAT-registered. Its company number (CBE) is 0876.435.778.
Where is the registered office of Nosele?
According to the CBE register, the registered office of Nosele is in 1150 Woluwe-Saint-Pierre.
What is the equity of Nosele?
At the close of the 2025 financial year, the equity of Nosele amounts to 263,979 €, a solvency of 72.4% of total assets.
How many people work at Nosele?
1.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Nosele?
The register lists 1 active mandates at Nosele. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Nosele
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →